EDIT - Editas Medicine - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

EDIT is currently covered by 15 analysts with an average price target of $4.43. This is a potential upside of $1.55 (53.82%) from yesterday's end of day stock price of $2.88.

Editas Medicine's activity chart (see below) currently has 114 price targets and 119 ratings on display. The stock rating distribution of EDIT is 52.5% BUY, 42.5% HOLD and 5% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.82% with an average time for these price targets to be met of 134.84 days.

Highest price target for EDIT is $5, Lowest price target is $1, average price target is $6.64.

Most recent stock forecast was given by JOEL BEATTY from BAIRD on 12-May-2025. First documented stock forecast 29-Feb-2016.

Currently out of the existing stock ratings of EDIT, 21 are a BUY (52.5%), 17 are a HOLD (42.5%), 2 are a SELL (5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$4

$1.12 (38.89%)

2 months 1 days ago
(12-May-2025)

1/6 (16.67%)

$2.5 (166.67%)

26

Sell

$9

6 months 28 days ago
(15-Dec-2024)

2/2 (100%)

$0.14 (1.58%)

9

Buy

$5

$2.12 (73.61%)

$7

6 months 28 days ago
(15-Dec-2024)

2/5 (40%)

$3.52 (237.84%)

7

$3

$0.12 (4.17%)

$5

7 months 1 days ago
(12-Dec-2024)

8/12 (66.67%)

$1.56 (108.33%)

200

Hold

$3

$0.12 (4.17%)

$11

7 months 1 days ago
(12-Dec-2024)

4/8 (50%)

$1.56 (108.33%)

38

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EDIT (Editas Medicine) average time for price targets to be met?

On average it took 134.84 days on average for the stock forecasts to be realized with a an average price target met ratio 47.82

Which analyst has the current highest performing score on EDIT (Editas Medicine) with a proven track record?

STEVEN SEEDHOUSE

Which analyst has the most public recommendations on EDIT (Editas Medicine)?

Steven Seedhouse works at RAYMOND JAMES and has 7 price targets and 5 ratings on EDIT

Which analyst is the currently most bullish on EDIT (Editas Medicine)?

Cory Kasimov with highest potential upside - $21.82

Which analyst is the currently most reserved on EDIT (Editas Medicine)?

Greg Harrison with lowest potential downside - -$1.88

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?